Patenting Of Human Genes

NPR's Richard Harris reports on the debate over efforts of private companies to patent human genes. When scientists began the process of charting the entire human genetic blueprint several years ago, information about the research was to flow into the public domain from a federally funded project. Now, many private companies involved in genetic research say they need patents to protect their medical products.

Copyright © 1999 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

Copyright © 1999 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.